Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes

NCT01499108 is registered in ClinicalTrials.gov with Peter Rossing as lead sponsor.

NCT NCT01499108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
Lead sponsor
Peter Rossing
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2012
Completion date
August 31, 2014
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes